EBV-associated nasopharyngeal carcinomas: from epidemiology to virus-targeting strategies

被引:104
作者
Busson, P
Keryer, C
Ooka, T
Corbex, M
机构
[1] CNRS, UMR 8126, F-94805 Villejuif, France
[2] Inst Gustave Roussy, F-94805 Villejuif, France
[3] CNRS, UMR 5537, F-69372 Lyon, France
[4] Fac Med Laennec, F-69372 Lyon, France
[5] Int Agcy Res Canc, Genet Epidemiol Unit, F-69372 Lyon, France
关键词
D O I
10.1016/j.tim.2004.06.005
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nasopharyngeal carcinoma is a human malignancy consistently associated with the Epstein-Barr virus. Exposure to non-viral carcinogens and genetic predisposition are other crucial etiologic factors. Tumor development appears to require the expression of a small subset of transforming viral RNAs and proteins with concomitant silencing of most other viral genes. Impairment of the interactions of viral proteins with cellular partners or disruption of viral latency might prove to be useful for novel therapeutic strategies.
引用
收藏
页码:356 / 360
页数:5
相关论文
共 34 条
[1]   Cancer epidemiology and control in Taiwan: a brief review [J].
Chen, CJ ;
You, SL ;
Lin, LH ;
Hsu, WL ;
Yang, YW .
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2002, 32 :S66-S81
[2]   A conditionally replicating adenovirus for nasopharyngeal carcinoma gene therapy [J].
Chia, MC ;
Shi, W ;
Li, JH ;
Sanchez, O ;
Strathdee, CA ;
Huang, D ;
Busson, P ;
Klamut, HJ ;
Liu, FF .
MOLECULAR THERAPY, 2004, 9 (06) :804-817
[3]  
Dardari R, 2001, INT J CANCER, V92, P294, DOI 10.1002/1097-0215(200102)9999:9999&lt
[4]  
::AID-IJC1177&gt
[5]  
3.0.CO
[6]  
2-9
[7]  
Decaussin G, 2000, CANCER RES, V60, P5584
[8]   Epstein-Barr virus and undifferentiated nasopharyngeal carcinoma: New immunobiological and molecular insights on a long-standing etiopathogenic association [J].
Dolcetti, R ;
Menezes, J .
ADVANCES IN CANCER RESEARCH, VOL 87, 2003, 87 :127-157
[9]   Potential selection of LMP1 variants in nasopharyngeal carcinoma [J].
Edwards, RH ;
Sitki-Green, D ;
Moore, DT ;
Raab-Traub, N .
JOURNAL OF VIROLOGY, 2004, 78 (02) :868-881
[10]   Inhibition of Epstein-Barr virus-induced growth proliferation by a nuclear antigen EBNA2-TAT peptide [J].
Farrell, CJ ;
Lee, JM ;
Shin, EC ;
Cebrat, M ;
Cole, PA ;
Hayward, SD .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (13) :4625-4630